The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 28.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 46% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (5 analysts) rates it buy, with a mean price target of $91.
Astronics Corporation
ATRO · Nasdaq · USD · Market cap $3.3B · 2,700 employees
Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace, defense, and electronics industries in the United States, rest of North America, Asia, Europe, South America, and inte…
FAIL · Does not pass the screenAt the last full screen
2026-09-04
Screened 2026-09-04 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Astronics Corporation holds its Markup at $76.26. Consolidating, no directional conviction, held for 17 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 17 days |
| Price at the screen | $76.26 |
| Valuation | 41.67 trailing · 24.23 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.20 |
Five Screens, Shown in Full
Does not pass. Prohibited business activity: Aerospace & Defense
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited business activity: Aerospace & Defense | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-04 screen. The gold marker is the market price at the same screen. A 6.8% margin of safety to the base estimate.
Third-party analyst targets: 5 covering, consensus Buy. The average target sits +31% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsDefence Parts Maker Hits Our Ethical Wall
Astronics builds the electronics and lighting that keep military jets and commercial planes in the air. Every contract it wins in aerospace and defence therefore lands it straight on the prohibited list. We pass without hesitation. The ethical screen exists for exactly these cases and we apply it cleanly.
Revenue is rising 12 percent and return on equity sits at 21 percent, yet the business still only clears a 5 percent profit margin while trading at 25.5 times forward earnings. A one percent margin of safety over our fair value adds no comfort when the core activity itself is off limits. Consensus targets sit higher, but that changes nothing for us.
Currency swings, defence budget cycles and thin margins already make the shares volatile. The ethical failure simply removes any reason to look further. Analysis, not advice.
| Forward P/E | 24.2xfairly priced for its growth rate |
| Trailing P/E | 41.7xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.83 |
| EPS, forward | 3.15 |
| Revenue growth | +27.0%strong top-line growth |
| Profit margin | 8.4%thin but positive margins |
| Return on equity | 33.7%an exceptional return on shareholder capital |
| FCF yield | 0.51% |
| Debt to equity | 1.78a meaningful debt load worth watching |
| Current ratio | 2.97comfortably covers its short-term bills |
| Beta | 1.20moves a little more than the market |
| Short interest, float | 0.09% |
| 52-week range | 29.43 - 94.46 |
| Market cap | $3.3B |
| Employees | 2,700 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeATRO trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 29.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 46% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (5 analysts) rates it buy, with a mean price target of $91.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 46% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 151%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (5 analysts) rates it buy, with a mean price target of $91.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $75.79 | +9.4% | · | $1,094 | +9.4% |
| 2 months | $72.49 | +14.4% | · | $1,144 | +14.4% |
| 3 months | $67.85 | +22.2% | · | $1,222 | +22.2% |
| 6 months | $54.80 | +51.4% | · | $1,514 | +51.4% |
| 1 year | $33.01 | +151.3% | · | $2,513 | +151.3% |
| 2 years | $18.63 | +345.2% | · | $4,452 | +345.2% |
| 3 years | $17.44 | +375.6% | · | $4,756 | +375.6% |
| 5 years | $19.23 | +331.3% | · | $4,313 | +331.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ATRO does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.